Technology Transfer Office | University of Colorado

U.S. Patents Awarded to CU

Technology Transfer Office of University of Colorado
Browse by Category
Life Science
Biomaterials
Diagnostic
Drug Delivery and Formulation
Medical Devices
Research Tool
Therapeutic
Physical Science
Chemicals and Materials
Copyrighted and Educational Material
Electronics
Energy
Mechanical Device
Micro and Nanotechnology
Optics
Process
Software
Test and Measurement
Latest Issued Patents
All U.S. Issued Patents
Issued Patents - Therapeutic-Drug Target (Total: 38)
Patent Title Patent No. Date Issued Available?
Targeting Complement Factor H for Treatment of Diseases 9,212,212 12/15/2015 No
Modulating the Alternative Complement Pathway 8,937,046 01/20/2015 No
Inhibition of the Alternative Complement Pathway for Treatment of Traumatic Brain Injury, Spinal Cord Injury and Related Conditions 8,911,733 12/16/2014 No
Method for eliciting an immune response to human telomerase reverse transcriptase 8,709,995 04/29/2014 No
Methods of Using AMPD2 Inhibitors for the Treatment of Fatty Liver, Obesity and Diabetes 8,697,628 04/15/2014 Yes
Targeting Complement Factor H For Treatment of Diseases 8,569,225 10/29/2013 No
Complement Receptor 2 Targeted Complement Modulators 8,007,804 09/24/2013 No
Complement Receptor 2 Targeted Complement Modulators 8,540,997 09/24/2013 No
Bacterial Replication Systems and Methods 8,431,376 04/30/2013 Yes
Systems and Methods for Treating Human Inflammatory and Proliferative Diseases With a Combination of Compounds, Or a Bifunctional Compound That Provides Fatty Acid Metabolism and Glycolysis Inhibition 8,329,753 12/11/2012 No
Compositions of UCP Inhibitors, FAS Antibody, A Fatty Acid Metabolism Inhibitor and/or A Glucose Metabolism Inhibitor 8,293,240 10/23/2012 No
Methods and Compositions For the Diagnosis and Treatment of Cyclin A-1 Associated Conditions 8,076,304 12/13/2011 Yes
Targeting Complement Factor H For Treatment of Diseases 7,759,304 07/20/2010 No
Antibody to Telomerase Reverse Transcriptive 7,750,121 07/06/2010 No
Human Telomerase Reverse Transcriptase Polypeptides 7,622,549 11/24/2009 No
Method Comprising Expressing Human Telomersase Reverse Transcriptase In Mammalian Cells, In Vitro 7,585,622 09/08/2009 No
Nucleic Acid Compositions for Eliciting an Immune Response Against Telomerase Reverse Transcriptase 7,560,437 07/14/2009 No
Muteins of Human Telomerase Reverse Transcriptase Lacking Telomerase Catalyctic Activity 7,517,971 04/14/2009 No
Compositions of UCP Inhibitors, Fas Antibody, a Fatty Acid Metabolism Inhibitor and/or a Glucose Metabolism Inhibitor 7,510,710 03/31/2009 No
Methods for Treating Human Proliferative Diseases, With a Combination of Fatty Acid Metabolism Inhibitors and Glycolytic Inhibitors 7,445,794 11/04/2008 No
Treating Cancer Using a Telomerase Vaccine 7,413,864 08/19/2008 No
Identifying and Testing Antisense Oligonucleotides That Inhibit Telomerase Reverse Transcriptase 7,297,488 11/20/2007 No
Antibody to Telomerase Reverse Transcriptase (Amended) See Telomerase/Cech files (7017, 7074, 7081, 7093, 7094, 8014, 8015, 8016). 7,285,639 10/23/2007 No
Nucleic Acids Encoding Human Telomerase Reverse Transcriptase and Related Homologs 7,262,288 08/28/2007 No
Mammalian Cells That Have Increased Proliferative Capacity (Amended) 7,195,911 03/27/2007 No
Telomerase Peptides and Immunogenic Compositions 7,056,513 06/06/2006 No
Methods for Detecting Nucleic Acids Encoding Human Telomerase Reverse Transcriptase (Amended) 7,005,262 02/28/2006 No
Genes for Human Telomerase Reverse Transcriptase and Telomerase Variants 6,927,285 08/09/2005 No
Vectors For Expressing Telomerase Reverse Transcriptase in Mammalian Cells 6,921,664 07/26/2005 No
Antisense Compositions for Detecting and Inhibiting Telomerase Reverse Transcriptase 6,627,619 09/30/2003 No
Cells Immortalized with Telomerase Reverse Transcriptase for Use in Drug Screening 6,617,110 09/09/2003 No
Promoter for Telomerase Reverse Transcriptase 6,610,839 08/26/2003 No
Human Telomerase Catalytic Subunit: Diagnostic and Therepeutic Methods 6,475,789 11/05/2002 No
Antisense Compositions for Detecting and Inhibiting Telomerase Reverse Transcriptase 6,444,650 09/03/2002 No
Novel Telomerase 6,309,867 10/30/2001 No
Novel Telomerase 6,261,836 07/17/2001 No
Detecting and Treating Heart Failure 5,733,728 03/31/1998 Yes
Screening for Mutations by Expressing CDNA Segments 5,656,425 08/12/1997 Yes
(For more issued patents, please click the categories to the left.) Export to Excel